Alexithymia in Ankylosing Spondylitis

Istanbul Medeniyet University

Status: Completed

Conditions: Ankylosing Spondylitis

Treatments: Diagnostic Test: Toronto Alexithymia Scale-20 (TAS-20); Diagnostic Test: Bath Ankylosing Spondylitis Functional Index (BASFI); Diagnostic Test: Beck's Depression Inventory (BDI); Diagnostic Test: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI); Diagnostic Test: Bath Ankylosing Spondylitis Metrology Index (BASMI); Diagnostic Test: Ankylosing Spondylitis Quality of Life Questionnaire (ASQoL)

Study type: Observational

Funder types: Other

Identifiers

NCT04320459

MedeniyetRomato

Details and patient eligibility

About

The study included 55 patients having Ankylosing Spondylitis (AS) for at least 1 year diagnosed according to the ASAS classification criteria who presented to our hospital's outpatient clinic and 55 healthy subjects. Demographic data were recorded for 55 AS patients who were subsequently assessed using the BASMI (Bath Ankylosing Spondylitis Metrology Index) in terms of elasticity and spinal mobility as well as the BASFI (Bath Ankylosing Spondylitis Functional Index) to determine functional status, the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) to assess the disease activity and the ASQoL (Ankylosing Spondylitis Quality of Life Questionnaire) to evaluate quality of life. The Toronto Alexithymia Scale-20 (TAS-20) was used for assessment of alexithymia and Beck's Depression Inventory (BDI) for depression among patients.

Full description

The study included 55 patients having Ankylosing Spondylitis (AS) for at least 1 year diagnosed according to the ASAS classification criteria who presented to our hospital's outpatient clinic and 55 healthy subjects. Demographic data were recorded for 55 AS patients who were subsequently assessed using the BASMI (Bath Ankylosing Spondylitis Metrology Index) in terms of elasticity and spinal mobility as well as the BASFI (Bath Ankylosing Spondylitis Functional Index) to determine functional status, the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) to assess the disease activity and the ASQoL (Ankylosing Spondylitis Quality of Life Questionnaire) to evaluate quality of life. The Toronto Alexithymia Scale-20 (TAS-20) was used for assessment of alexithymia and Beck's Depression Inventory (BDI) for depression among patients.

Enrollment: 110 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Diagnosed as AS for at least 1 year according to the ASAS classification criteria
• over 18 years old

Exclusion criteria

• fibromyalgia
• age less than 18 years
• vision and hearing impairment
• neurological disease (Parkinson's disease, multiple sclerosis, cerebrovascular disease),
• history of a psychiatric disorder (schizophrenia, bipolar disorder)
• history of chronic condition (DM, thyroid disease) or malignancy

Trial design

110 participants in 2 patient groups

ankylosing spondylitis

Description:

55 patients having Ankylosing Spondylitis (AS) for at least 1 year diagnosed according to the ASAS classification criteria who presented to our hospital's outpatient clinic

Treatment:

Diagnostic Test: Bath Ankylosing Spondylitis Metrology Index (BASMI)

Diagnostic Test: Bath Ankylosing Spondylitis Functional Index (BASFI)

Diagnostic Test: Beck's Depression Inventory (BDI)

Diagnostic Test: Toronto Alexithymia Scale-20 (TAS-20)

Diagnostic Test: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)

Diagnostic Test: Ankylosing Spondylitis Quality of Life Questionnaire (ASQoL)

healthy control

Description:

age and sex matched healthy controls

Treatment:

Diagnostic Test: Bath Ankylosing Spondylitis Metrology Index (BASMI)

Diagnostic Test: Bath Ankylosing Spondylitis Functional Index (BASFI)

Diagnostic Test: Beck's Depression Inventory (BDI)

Diagnostic Test: Toronto Alexithymia Scale-20 (TAS-20)

Diagnostic Test: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)

Diagnostic Test: Ankylosing Spondylitis Quality of Life Questionnaire (ASQoL)